cimetidine has been researched along with metronidazole in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (26.09) | 18.7374 |
1990's | 12 (26.09) | 18.2507 |
2000's | 12 (26.09) | 29.6817 |
2010's | 10 (21.74) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, Y; Ishikawa, H; Katsura, Y; Matsumoto, Y; Sakane, K; Takasugi, H; Tomishi, T | 1 |
Ishikawa, H; Katsura, Y; Matsumoto, Y; Nishino, S; Sakane, K; Takasugi, H; Tomishi, T | 1 |
Ishikawa, H; Katsura, Y; Matsumoto, Y; Morinaga, C; Nishino, S; Ohno, M; Sakane, K; Takasugi, H | 1 |
Topliss, JG; Yoshida, F | 1 |
Inoue, Y; Ishikawa, H; Katsura, Y; Matsumoto, Y; Morinaga, C; Sakane, K; Takasugi, H; Tomishi, T | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Inoue, Y; Ishikawa, H; Katsura, Y; Matsumoto, Y; Morinaga, C; Nishino, S; Sakane, K; Takasugi, H | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Amplatz, S; Benvenuti, S; Di Fede, F; Dobrilla, G; Piazzi, L | 1 |
Blaser, MJ; Lind, CD | 1 |
Dubé, S; Heyen, F | 1 |
Quintero Diaz, M; Sotto Escobar, A | 1 |
Barker, LA; Winbery, SL | 1 |
Bjerrum, K; Dalhof, K; Døssing, M; Loft, S; Poulsen, HE; Sonne, J | 1 |
Berlatzky, Y; Rubinger, D; Zylber-Katz, E | 1 |
Haataja, H; Männistö, PT; Saijonmaa, O | 1 |
Døssing, M; Jørgensen, BG; Loft, S; Petersen, KT; Poulsen, HE; Sonne, J | 1 |
Armstrong, JA; Goodwin, CS; Wee, SH; Wilson, DH | 1 |
Höchter, W; Ottenjann, R; Wörmann, B | 1 |
de Vries, J; Staiger, C; Wang, NS; Weber, E | 1 |
Gugler, R; Jensen, JC | 1 |
Baud, F; Bismuth, C; Elkhouly, M; Galliot, M; Pontal, PG | 1 |
Ahmad, S | 1 |
Kadish, U; Neeman, A | 1 |
Boyd, EJ; Boyd, HK; Chinzon, D; Eisig, JN; Iriya, K; Laudanna, AA; Zaterka, S | 1 |
Hoshiko, K; Maeda, K; Murayama, H; Nakahara, T; Nakayama, Y; Oda, K; Oh, K; Okabe, N; Okada, M; Okumura, M; Seo, M; Shirotani, T | 1 |
Elizondo, G; Ostrosky-Wegman, P | 1 |
Cai, S; Castela-Papin, N; Farinotti, R; Keller, F; Souleau, CH; Vatier, J | 1 |
Chen, J; Chen, SY; Wang, JY; Zhang, SS; Zhang, XD | 1 |
Akao, T; He, JX; Nishino, T; Tani, T | 1 |
Ermolaev, IA; Nazarov, VE; Rukhliada, NV | 1 |
4 review(s) available for cimetidine and metronidazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combination; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Stomach Ulcer | 1992 |
Helicobacter pylori and duodenal ulceration.
Topics: Cimetidine; Duodenal Ulcer; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Recurrence | 1991 |
[Drug-induced colitis].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bone Marrow Transplantation; Cholestyramine Resin; Cimetidine; Colitis; Contraceptives, Oral, Hormonal; Enema; Ergotamine; Flucytosine; Gold; Graft vs Host Reaction; Humans; Hydrogen Peroxide; Methyldopa; Metronidazole; Ranitidine; Suppositories; Vancomycin; Vasopressins | 1985 |
7 trial(s) available for cimetidine and metronidazole
Article | Year |
---|---|
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combination; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Stomach Ulcer | 1992 |
Metronidazole versus cimetidine in treatment of gastroduodenal ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Female; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Random Allocation; Stomach Ulcer | 1986 |
[Effect of metronidazole on phenazone metabolism].
Topics: Adult; Antipyrine; Cimetidine; Drug Interactions; Female; Humans; Hydroxylation; Kinetics; Male; Metronidazole; Time Factors | 1984 |
Selection of patients for treatment of duodenal ulcer infected with Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Selection; Ranitidine; Recurrence; Retrospective Studies; Time Factors | 1994 |
Helicobacter pylori and refractory duodenal ulcers: cross-over comparison of continued cimetidine with cimetidine plus antimicrobials.
Topics: Adult; Amoxicillin; Cimetidine; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Time Factors | 1994 |
Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: randomized controlled study in Japan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cimetidine; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Prognosis; Recurrence; Treatment Outcome; Wound Healing | 1996 |
Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; China; Cimetidine; Cost-Benefit Analysis; Disease Management; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Treatment Outcome | 1999 |
36 other study(ies) available for cimetidine and metronidazole
Article | Year |
---|---|
Anti-Helicobacter pylori agents. 1. 2-(Alkylguanidino)-4-furylthiazoles and related compounds.
Topics: Animals; Anti-Bacterial Agents; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Receptors, Histamine H2; Structure-Activity Relationship | 1997 |
Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles.
Topics: Animals; Anti-Bacterial Agents; Dogs; Gastric Acid; Guanidines; Guinea Pigs; Heart Atria; Helicobacter pylori; Histamine H2 Antagonists; In Vitro Techniques; Microbial Sensitivity Tests; Rats; Structure-Activity Relationship; Thiazoles | 1998 |
Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
Topics: Animals; Anti-Bacterial Agents; Atrial Function; Colony Count, Microbial; Gastric Acid; Guanidines; Guinea Pigs; Heart Atria; Helicobacter pylori; Histamine H2 Antagonists; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Receptors, Histamine H2; Structure-Activity Relationship; Thiazoles | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives.
Topics: Animals; Anti-Bacterial Agents; Gastric Acid; Guanidines; Helicobacter pylori; Histamine H2 Antagonists; Male; Microbial Sensitivity Tests; Ranitidine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Gastric Juice; Guanidines; Guinea Pigs; Helicobacter pylori; Histamine H2 Antagonists; In Vitro Techniques; Male; Microbial Sensitivity Tests; Myocardium; Oxazoles; Rats; Structure-Activity Relationship; Thiazoles; Thiophenes | 2002 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Pouchitis and gastric hyposecretion: cause or effect?
Topics: Adenomatous Polyposis Coli; Adult; Anal Canal; Anastomosis, Surgical; Cimetidine; Colitis, Ulcerative; Gastric Acid; Humans; Ileitis; Ileum; Intestinal Mucosa; Metronidazole; Postoperative Complications | 1990 |
Metronidazole and 5-aminosalicylic acid enhance the contractile activity of histaminergic agonists on the guinea-pig isolated ileum.
Topics: Aminosalicylic Acids; Animals; Cimetidine; Computers; Dimaprit; Dose-Response Relationship, Drug; Drug Synergism; Duodenum; Female; Guinea Pigs; Heart; Histamine; Ileum; In Vitro Techniques; Jejunum; Male; Mesalamine; Metronidazole; Muscle Contraction; Myenteric Plexus; Pyrilamine; Receptors, Histamine; Scopolamine; Tetrodotoxin; Thiourea | 1986 |
Lack of effect of cimetidine on the pharmacokinetics and metabolism of a single oral dose of metronidazole.
Topics: Administration, Oral; Adult; Cimetidine; Female; Humans; Male; Metronidazole | 1988 |
Cyclosporine interactions with metronidazole and cimetidine.
Topics: Adult; Cimetidine; Cyclosporins; Diabetic Nephropathies; Drug Interactions; Female; Humans; Kidney Transplantation; Metronidazole | 1988 |
Effect of enzyme induction and inhibition on the fate of metronidazole and tinidazole in the rat.
Topics: Animals; Bile; Biotransformation; Chromatography, High Pressure Liquid; Cimetidine; Enzyme Induction; Enzyme Inhibitors; Male; Metronidazole; Nitroimidazoles; Phenobarbital; Rats; Rats, Inbred Strains; Tinidazole | 1987 |
Inhibition and induction of metronidazole and antipyrine metabolism.
Topics: Adult; Antipyrine; Cimetidine; Drug Interactions; Female; Humans; Hydroxylation; Kinetics; Male; Metronidazole; Phenobarbital | 1987 |
Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter; Cell Wall; Cephalexin; Cimetidine; Clindamycin; Erythromycin; Metronidazole; Microscopy, Electron; Organometallic Compounds; Penicillin G | 1987 |
Interaction between cimetidine and metronidazole.
Topics: Cimetidine; Drug Interactions; Humans; Metabolic Clearance Rate; Metronidazole | 1983 |
[Prolonged high plasma imipramine levels after acute intoxication (author's transl)].
Topics: Adult; Cimetidine; Critical Care; Female; Humans; Imipramine; Liver; Metronidazole | 1982 |
Drug interactions with oral anticoagulants.
Topics: Anticoagulants; Benzothiadiazines; Cimetidine; Clofibrate; Dipyridamole; Diuretics; Drug Interactions; Humans; Metronidazole; Sodium Chloride Symporter Inhibitors; Sulfinpyrazone | 1980 |
Effects of metronidazole and its metabolites on histamine immunosuppression activity.
Topics: Adult; Analysis of Variance; Cell Division; Cells, Cultured; Cimetidine; Histamine; Histamine Antagonists; Humans; Immunosuppressive Agents; Lymphocyte Activation; Metronidazole; Mitosis; Molecular Structure; T-Lymphocytes, Helper-Inducer | 1996 |
Drug interactions with diosmectite: a study using the artificial stomach-duodenum model.
Topics: Adsorption; Animals; Anti-Infective Agents; Cimetidine; Dapsone; Digoxin; Drug Interactions; Duodenum; Fluoroquinolones; Gastric Mucosa; Gastrointestinal Agents; Hydrogen-Ion Concentration; Intestinal Absorption; Metronidazole; Models, Biological; Pharmacokinetics; Silicates; Stomach; Swine; Valproic Acid | 1999 |
The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang.
Topics: Amoxicillin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Area Under Curve; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Cimetidine; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Feces; Glycyrrhiza; Glycyrrhizic Acid; Hydrolysis; Male; Metronidazole; Muscarinic Antagonists; Omeprazole; Paeonia; Peptic Ulcer; Phytotherapy; Rats; Rats, Wistar | 2001 |
[Pharmacotherapy in complex treatment of ulcerous stenosis].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Pyloric Stenosis; Ranitidine; Time Factors | 2003 |